ANR-DFG - Appel à projets générique 2018 - DFG

Functional analysis of the cGAS/STING axis during bacterial and viral infections and implications for the development of innovative vaccines – cGAS-Vac

Submission summary

The cGAS/STING innate immune sensor pathway plays a key role for the induction of protective immunity against many DNA-encoded pathogens, including intracellular bacteria and viruses. While during the last years a great body of knowledge accumulated regarding the response of the cGAS/STING pathway to synthetic molecules and representative cell types, there is much less understanding of how and where the pathway is engaged by actual pathogens in in vivo settings, and which other signaling platforms might work in concert with cGAS/STING. This is a critical question, because infections involve different phases of pathogen replication, and immune responses are contributed by various cell types and tissues to confer protective immunity. At the molecular level, it is also unsolved which kinds of DNAs bind to cGAS to stimulate cGAMP formation that triggers STING and thus elicits cytokine responses. To address these questions, we will apply advanced animal models. In brief, we will study Listeria monocytogenes (LM) and mouse cytomegalovirus (MCMV) infection of mice, which are devoid of cGAS/STING signaling alone or in combination with Toll-like receptor (TLR) & RIG-I-like helicases (RLH) signaling. For MCMV, a special emphasis will be laid on the role of the cGAS/STING axis in restricting viral dissemination from liver to other organs. Furthermore, mice that have knock-in alleles of cGAS and STING that are fused to functional protein tags will be used. These models will help us to understand the function of the cGAS/STING-axis in different cells as well as tissues. We will apply cutting edge technology to identify DNAs binding to cGAS in the context of infections and we will study STING function on the cellular and tissue level. The newly obtained data will be exploited to develop innovative vaccine vectors containing the STING ligand cGAMP as an adjuvant. This project will be carried out by a consortium of three research teams, two from Germany and one from France, who are experts in reverse genetics of MCMV, innate immune signaling, and anti-viral immunity. This project will include secondment of PhD students/postdocs to the collaborating partner laboratories and biannual retreats. By these measures plus regular video lab meetings a high degree of interaction between the involved labs and a maximal productivity will be assured.

Project coordination

Xavier Lahaye (INSTITUT CURIE - SECT DE RECHERCHE)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

INSTITUT CURIE - SECT DE RECHERCHE
University Medical Center Freiburg, Institute of Virology, Freiburg, Germany
TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Center for Infection Research and the Hanover Medical School, Hannover

Help of the ANR 316,469 euros
Beginning and duration of the scientific project: December 2018 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter